Literature DB >> 11691798

Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer.

H Zhao1, M R Spitz, G E Tomlinson, H Zhang, J D Minna, X Wu.   

Abstract

Gamma-radiation results in cell cycle arrest and apoptosis in a wide variety of cells. Cell cycle arrest provides time for the cell to repair damaged DNA before entering the next phase of the cycle. If the damage is severe and cannot be repaired, the cells undergo apoptosis. However, if the damaged cells continue to grow without repair or apoptosis, then carcinogenic transformation may occur. We hypothesized that individuals with inherited disruption in cell cycle control and/or apoptosis and/or DNA repair may be susceptible to lung cancer development. The cells from susceptible individuals would have a shorter G2 period and less apoptosis compared with cells from normal individuals upon exposure to gamma-radiation. To test this hypothesis, the following methods were used: (a) fluorescence-activated cell sorting method was used to measure apoptosis and G2 cell cycle delay; (b) the ELISA method was used to measure p53 protein expression levels in these cell lines; and (c) gamma-radiation-induced chromatid breaks were counted as a marker for DNA damage or repair. Next, gamma-radiation-induced G2 delay and apoptosis were tested in three lymphoblastoid cell lines to determine the dose response effect and optimal time points of gamma-radiation. Finally, these assays were tested in lymphoblastoid cell lines from 30 lung cancer patients and 22 healthy controls. We found a dose-response relationship for gamma-radiation-induced G2 delay and apoptosis. The optimal time points to detect differential G2 delay and apoptotic index were 10 h and 48 h after gamma-radiation, respectively. The mean G2 delay was 22.5% +/- 10.5% for the control cell lines and 14.71% +/- 8.8% for case cell lines (P < 0.01). The mean apoptotic index was 20.4% +/- 11.7% for the controls and 14.3% +/- 7.8% for the cases (P < 0.05). The controls had a significantly higher p53 response ratio and fewer chromatid breaks than the cases. We also found that a p53 increasing ratio was strongly related to cell cycle G2 delay (gamma = 0.413; P = 0.002) and chromatid breaks (gamma =0.384; P = 0.028). Therefore, we concluded that gamma-radiation-induced G2 delay, apoptosis, p53 increasing ratio, and chromatid breaks might potentially be used as susceptibility markers for lung cancer risk. A large epidemiology study is in progress to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11691798

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Reticulocyte and micronucleated reticulocyte responses to gamma irradiation: dose-response and time-course profiles measured by flow cytometry.

Authors:  Stephen D Dertinger; Ying Tsai; Irena Nowak; Ollivier Hyrien; Hongliang Sun; Jeffrey C Bemis; Dorothea K Torous; Peter Keng; James Palis; Yuhchyau Chen
Journal:  Mutat Res       Date:  2007-07-05       Impact factor: 2.433

2.  GADD34 suppresses wound healing by upregulating expression of myosin IIA.

Authors:  Chie Tanaka; Sachiko Ito; Naomi Nishio; Yasuhiro Kodera; Hidetoshi Sakurai; Haruhiko Suzuki; Akimasa Nakao; Ken-Ichi Isobe
Journal:  Transgenic Res       Date:  2009-11-22       Impact factor: 2.788

3.  Apoptotic capacity and risk of squamous cell carcinoma of the head and neck.

Authors:  Zhensheng Liu; Hongliang Liu; Peng Han; Fengqin Gao; Kristina R Dahlstrom; Guojun Li; Kouros Owzar; Jose P Zevallos; Erich M Sturgis; Qingyi Wei
Journal:  Eur J Cancer       Date:  2016-12-26       Impact factor: 9.162

4.  Combined low dose ionizing radiation and green tea-derived epigallocatechin-3-gallate treatment induces human brain endothelial cells death.

Authors:  Nancy McLaughlin; Borhane Annabi; Marie-Paule Lachambre; Kwang Sik Kim; Jean-Paul Bahary; Robert Moumdjian; Richard Béliveau
Journal:  J Neurooncol       Date:  2006-05-19       Impact factor: 4.130

Review 5.  Gene polymorphisms, apoptotic capacity and cancer risk.

Authors:  Evgeny N Imyanitov
Journal:  Hum Genet       Date:  2009-02-12       Impact factor: 4.132

6.  Identification of thymidylate synthase as a potential therapeutic target for lung cancer.

Authors:  K Takezawa; I Okamoto; S Tsukioka; J Uchida; M Kiniwa; M Fukuoka; K Nakagawa
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

7.  Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs.

Authors:  T Iwasa; I Okamoto; K Takezawa; K Yamanaka; T Nakahara; A Kita; H Koutoku; M Sasamata; E Hatashita; Y Yamada; K Kuwata; M Fukuoka; K Nakagawa
Journal:  Br J Cancer       Date:  2010-06-01       Impact factor: 9.075

8.  Evidence for significant heritability of apoptotic and cell cycle responses to ionising radiation.

Authors:  Paul Finnon; Naomi Robertson; Sylwia Dziwura; Claudine Raffy; Wei Zhang; Liz Ainsbury; Jaakko Kaprio; Christophe Badie; Simon Bouffler
Journal:  Hum Genet       Date:  2008-04-25       Impact factor: 4.132

9.  ATM sequence variants associate with susceptibility to non-small cell lung cancer.

Authors:  Hushan Yang; Margaret R Spitz; David J Stewart; Charles Lu; Ivan P Gorlov; Xifeng Wu
Journal:  Int J Cancer       Date:  2007-11-15       Impact factor: 7.396

10.  Irradiation-induced telomerase activity and gastric cancer risk: a case-control analysis in a Chinese Han population.

Authors:  Xianli He; Qing Qiao; Naijian Ge; Jing Nan; Shuqun Shen; Zizhong Wang; Yefa Yang; Guoqiang Bao
Journal:  BMC Cancer       Date:  2010-06-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.